ACCOUNTS - Final Accounts preparation

Company registration number: 10963006

	FINANCIAL STATEMENTS
	FOR THE YEAR ENDED 31 DECEMBER 2025

	LAMBOO MEDICAL LTD


LAMBOO MEDICAL LTD REGISTERED NUMBER:10963006

STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2025

		2025		2024
Note		£		£

Fixed assets
Tangible assets	4		76,072		116,879
			76,072		116,879
Current assets
Stocks		34,700		33,250
Debtors: amounts falling due within one year	5	1,341,616		956,580
Bank and cash balances		18,277		39,411
		1,394,593		1,029,241
Creditors: amounts falling due within one year	6	(428,123)		(370,564)
Net current assets			966,470		658,677
Total assets less current liabilities			1,042,542		775,556
Provisions for liabilities
Deferred tax	8	(18,421)		(28,964)
			(18,421)		(28,964)
Net assets			1,024,121		746,592

Capital and reserves
Allotted, called and fully paid share capital	10,000	10,000
Profit and loss account	1,014,121	736,592
	1,024,121	746,592

Page 1


LAMBOO MEDICAL LTD REGISTERED NUMBER:10963006

STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 DECEMBER 2025

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

................................................

J. M. Lamboo

Director

Date: 19 May 2026

The notes on pages 3 to 8 form part of these financial statements.

Page 2


LAMBOO MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

1.	General information

Lamboo Medical Ltd is a private company, limited by shares, registered in England and Wales. The Company's registered number and registered office address can be found on the Company Information page.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

2.3

Operating lease commitments

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

2.4

Revenue

Revenue represents the total invoice value, excluding value added tax, trade discounts and all other taxes of sales made during the year.

2.5

Revenue recognition

Revenue is recognised when goods have been delivered and services supplied to customers such that risks and rewards of ownership have transferred to them.

Revenue from ongoing support contracts is spread over the life of the contract according to the level of costs expected to be incurred as the contract is performed.

Page 3


LAMBOO MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.6

Leased assets: the Company as lessee

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance lease are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.8

Related party exemption

The Company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidaries within the group.

2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4


LAMBOO MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:

∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and

∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

				Plant and machinery	-	20%
				Motor vehicles	-	20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 5


LAMBOO MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.12

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

2.13

Financial Instruments

Financial instruments are recognised in the Company's Statement of Financial position when the Company becomes party to the contractual provisions of the instrument.

Employees

The average monthly number of employees, including directors, during the year was 13 (2024 - 11).

4.	Tangible fixed assets

	Plant and machinery	Motor vehicles	Total
	£	£	£
Cost or valuation
At 1 January 2025	93,599	169,485	263,084
Additions	3,277	-	3,277
Disposals	-	(18,000)	(18,000)
At 31 December 2025	96,876	151,485	248,361
Depreciation
At 1 January 2025	74,168	72,037	146,205
Charge for the year on owned assets	7,287	30,497	37,784
Disposals	-	(11,700)	(11,700)
At 31 December 2025	81,455	90,834	172,289
Net book value
At 31 December 2025	15,421	60,651	76,072
At 31 December 2024	19,431	97,448	116,879

Page 6


LAMBOO MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

Debtors

					2025	2024
					£	£


Trade debtors	246,189	349,089
Amounts owed by group undertakings	925,804	446,515
Other debtors	35,696	23,861
Prepayments and accrued income	133,927	137,115
	1,341,616	956,580

6.	Creditors: Amounts falling due within one year
		2025	2024
		£	£

Trade creditors	53,929	158,440
Corporation tax	103,673	129,574
Other taxation and social security	86,396	34,500
Obligations under finance lease and hire purchase contracts	-	1,157
Other creditors	5,110	2,403
Accruals and deferred income	179,015	44,490
	428,123	370,564

The following liabilities were secured:
	2025	2024
	£	£


Hire purchase contracts	-	1,157
	-	1,157

Details of security provided:

Amount due under hire purchase contracts are secured against the assets concerned.

Page 7


LAMBOO MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

7.	Amounts due under non-cancellable operating leases
		2024	2024
		£	£


Within one year	95,445	89,877
Between one and five years	126,200	209,715
More than five years	-	-
	221,645	299,592

8.	Deferred taxation

		2025
		£

	At beginning of year	(28,964)
	Charged to profit or loss	10,543
	At end of year	(18,421)

The provision for deferred taxation is made up as follows:
	2025	2024
	£	£

Accelerated capital allowances	(19,018)	(29,220)
Pension surplus	597	256
	(18,421)	(28,964)

9.	Controlling party

The immediate and ultimate parent company is Lamboo Medical Holding B.V., a company incorporated in the Netherlands at Michael Faradaystraat 2, 2712 PR ZOETERMEER, Netherlands. This is the largest and smallest group in which the company's accounts are consolidated.

10.	Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2025 was unqualified.

The audit report was signed on 21 May 2026 by J E Fox ACA FCCA (Senior Statutory Auditor) on behalf of Menzies LLP.

Page 8